A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Clinical trial NCT04832854 · TERMINATED
Trial details
- NCT number
- NCT04832854
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2025-03-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.